Eversept Partners »

EXACT Sciences Corporation shares owned by Eversept Partners

Quarter-by-quarter ownership of EXACT Sciences Corporation (EXAS) shares owned by Eversept Partners from 13F filings

Historical chart of Eversept Partners investment in EXACT Sciences Corporation

Tip: Access up to 7 years of quarterly data

All positions including EXACT Sciences Corporation held by Eversept Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in EXACT Sciences Corporation by Eversept Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $25M 242k 101.56

More positions owned by Eversept Partners

Vera Therapeutics Cl A (VERA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
GSK Sponsored Adr (GSK)
United Therapeutics Corporation (UTHR)
Abivax Sa Sponsored Ads (ABVX)
Natera (NTRA)
Syndax Pharmaceuticals (SNDX)
Miragen Therapeutics (VRDN)
Vaxcyte (PCVX)
Travere Therapeutics (TVTX)
Hca Holdings (HCA)
Danaher Corporation (DHR)
Ionis Pharmaceuticals (IONS)
Celldex Therapeutics Com New (CLDX)
Bruker Corporation (BRKR)

View all positions for Eversept Partners

Top funds holding EXACT Sciences Corporation

FMR
Vanguard Group
BlackRock
Wellington Management Company
Citadel Advisors
State Street Corporation
Norges Bank Investment Management
Geode Capital Management
UBS Group
Massachusetts Financial Services
Canada Pension Plan Investment Board
Beryl Capital Management
Millennium Management
Bamco
Qube Research & Technologies

View all funds holding EXACT Sciences Corporation